SACRAMENTO, CA – Setting a national precedent, California will sell its own state-branded insulin, making life-saving diabetes medication affordable for millions. Governor Gavin Newsom announced that ...

ORLANDO, FLORIDA / ACCESS Newswire / October 17, 2025 / RedChip Companies will air interviews with Nexalin Technology, Inc. (Nasdaq:NXL) and BioVie, Inc. (Nasdaq:BIVI) on the RedChip Small Stocks, Big ...

Civica will begin selling a type of insulin on Jan. 1, 2026, although it will not come from the nonprofit drug maker’s Petersburg facility.

Lower-cost insulin manufactured by the state of California will be available to consumers starting Jan. 1, 2026, for about ...

Governor Newsom makes major announcement on lowering drug costs Courtesy of the Office of the Governor BREAKING: Former Trump National Security Adviser John Bolton surrenders to 18 counts Cardiologist ...

The state's top officials just announced a landmark initiative to slash insulin prices, beginning on this date.

The sale of insulin is part of the state’s CalRx initiative aimed at lowering prescription drug prices for Californians.

California is set to start selling low-cost insulin pens this January, the first such move by a state to circumvent the ...

The pens are part of an initiative to “fundamentally lower health care costs, not spread” them, Gov. Gavin Newsom said.

Medicare beneficiaries face higher costs, reduced services, and possible cuts to the program at large—but there’s good news about prices for some drugs and the medication payment plan.

California will offer CalRx-branded biosimilar insulin glargine pens for $11 per pen beginning January 1, 2026.

California's first insulin pens will be for sale two years after the governor’s promised delivery date in 2024.